At around mark 7:45 the new chains are discussed. He says that one of the chains is a food drug store operator that is ranked in the top 10 nationally in terms of the number of pharmacies in store. He said that the 4 chains have over 2000 pharmacies..and that the smaller one of these chains will stock "only nexafed"
cc is worth a listen..but I wish there was a transcript
..I think now is an opportunity
"....At the other end, 1 small chain has indicated they will remove all nontamper-resistant 30 milligram pseudoephedrine products from their shelves and will only offer NEXAFED. We feel our launch of NEXAFED continues to progress and build momentum. We plan to continue to build on these distribution successes and expand our distribution further, especially as we enter the allergy season, which we believe is the prime sale season for pseudoephedrine products. We also will be testing direct-to-consumer advertising in May with an ad in a special USA Today allergy supplement. We continue to advance development of additional combination products in the NEXAFED franchise and continue to work on a second-generation technology..."
What i don't understand is why is the stock price going down with this news. It seems to me that the stock should have jumped, just like the time when they made the Kerr announcement. Maybe it will once acura reveals the actual names...
"Regarding OXECTA, it was our understanding that Pfizer would not commence any material physician promotion without first receiving comments from the FDA on their proposed physician promotion materials. Pfizer submitted their proposed promotional materials to the FDA in July 2012, and as such, sales to date remained nominal. Pfizer received comments on their proposed promotional campaign from the FDA in mid-April and is currently formulating their commercialization plans based on those comments."